Bottom line is....the company is developing a treatment for cervical cancer. the technology is sound, and the phase 2b results were great.
My view is that this should be the driver behind an increased SP.
The anticipation of a NASDAQ listing has clearly overshadowed the promising clinical results.
How unfortunate...share price should be a lot higher. Seriously undervalued stock.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
25.8¢ |
Change
0.008(3.00%) |
Mkt cap ! $379.7M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 26.0¢ | 24.5¢ | $563.9K | 2.237M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 170179 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 669279 | 19 |
View Market Depth
| Last trade - 12.23pm 17/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |